Literature DB >> 25966426

Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography.

Kristina I Ringe1, Frank Wacker2.   

Abstract

The purpose of radiological imaging in patients with suspected or known cholangiocarcinoma (CCA) is tumour detection, lesion characterization and assessment of resectability. Different imaging modalities are implemented complementary in the diagnostic work-up. Non-invasive imaging should be performed prior to invasive biliary procedures in order to avoid false positive results. For assessment of intraparenchymal tumour extension and evaluation of biliary and vascular invasion, MRI including MRCP and CT are the primarily used imaging modalities. The role of PET remains controversial with few studies showing benefit with the detection of unexpected metastatic spread, the differentiation between benign and malignant biliary strictures, and for discriminating post therapeutic changes and recurrent CCA.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Computed tomography; Magnetic resonance imaging; Positron emission tomography

Mesh:

Substances:

Year:  2015        PMID: 25966426     DOI: 10.1016/j.bpg.2015.02.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  9 in total

Review 1.  Imaging of Cholangiocarcinoma.

Authors:  Susann-Cathrin Olthof; Ahmed Othman; Stephan Clasen; Christina Schraml; Konstantin Nikolaou; Malte Bongers
Journal:  Visc Med       Date:  2016-12-06

Review 2.  Surgical options for intrahepatic cholangiocarcinoma.

Authors:  Kui Wang; Han Zhang; Yong Xia; Jian Liu; Feng Shen
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

Review 3.  Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors:  Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

Review 4.  [Diseases and diagnosis of the biliary system : When does the gastroenterologist need the radiologist?]

Authors:  Thomas von Hahn; K I Ringe; A Potthoff
Journal:  Radiologe       Date:  2019-04       Impact factor: 0.635

5.  Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Antonio Avallone; Raffaele Palaia; Gerardo Botti; Fabiana Tatangelo; Francesco Granata; Marco Cascella; Francesco Izzo; Antonella Petrillo
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

6.  Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand.

Authors:  Metha Songthamwat; Nittaya Chamadol; Narong Khuntikeo; Jadsada Thinkhamrop; Supinda Koonmee; Nathaphop Chaichaya; Jeffrey Bethony; Bandit Thinkhamrop
Journal:  World J Surg Oncol       Date:  2017-09-20       Impact factor: 2.754

7.  Radiological assessment of secondary biliary tree lesions: an update.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venanzio Setola; Antonio Avallone; Raffaele Palaia; Roberto Grassi; Francesco Izzo; Antonella Petrillo
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

Review 8.  Primary or metastatic hepatic carcinoma? A breast cancer patient after adjuvant chemotherapy and radiotherapy postoperatively with intrahepatic cholangiocarcinoma and review of the literature.

Authors:  Zhao-Yun Liu; Ju-Jie Sun; Ke-Wen He; Pei-Ying Zhuo; Zhi-Yong Yu
Journal:  World J Surg Oncol       Date:  2016-07-15       Impact factor: 2.754

Review 9.  Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas.

Authors:  Piera Zaccari; Vincenzo Cardinale; Carola Severi; Federica Pedica; Guido Carpino; Eugenio Gaudio; Claudio Doglioni; Maria Chiara Petrone; Domenico Alvaro; Paolo Giorgio Arcidiacono; Gabriele Capurso
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.